SAR-441000

N/A

Report date: 2026/04/13 20:02:18
NME

Base Information

Drug NameSAR-441000
Drug Alias NameSAR441000SAR-441000BNT-131
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionInterleukin-12 subunit alpha stimulantsInterleukin-12 subunit beta stimulantsInterferon alpha-2 stimulants +[5] 
TargetsInterleukin-12 subunit alphaInterleukin-12 subunit betaInterferon alpha-2 +[5] 
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiontech SeSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiBiontech Rna Pharmaceuticals Gmbh
Active IndicationsN/A
Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A